MARKETS

Company Info

QUATERLY RESULTS

Glenmark Pharmaceuticals Ltd.

You can view the quaterly results for the last 5 years.

BSE

Jul 14, 02:47

2217.40 +35.85 (+ 1.64%)

Volume 227213

Prev. Close 2181.55

Open Price 2164.85

Today's Low / High

2136.55

2229.00

Bid Price(Qty.) 2213.25 (6)

Open Pr.(Qty.) 2214.70 (14)

52 Wk Low / High

1274.70

2286.15

NSE

Jul 14, 02:39

2210.60 +29.50 (+ 1.35%)

Volume 3142748

Prev. Close 2181.10

Open Price 2170.10

Today's Low / High

2138.50

2229.00

Bid Price(Qty.) 2210.50 (155)

Open Pr.(Qty.) 2211.50 (36)

52 Wk Low / High

1275.50

2284.80

ISIN No	INE935A01035	Market Cap. ( ₹ in Cr. )	62383.31	P/BV	7.39	Book Value ( ₹ )	299.28
BSE Code	532296	52 Week High/Low ( ₹ )	2285/1276	FV/ML	1/1	P/E(X)	59.58
NSE Code	GLENMARKEQ	Book Closure	27/09/2024	EPS ( ₹ )	37.10	Div Yield (%)	0.11

(₹ in Crs.)

Particulars	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24
Net Sales/Income from operations	3220.13	3301.90	3400.50	3223.30	3062.95
Other Operating Income	36.07	85.65	33.30	20.88	0.00
Total Income From Operations	3256.21	3387.55	3433.80	3244.19	3062.95

EXPENDITURE
Consumption of Raw Materials	794.78	746.37	774.36	685.77	754.31
Purchase of Traded Goods	344.74	418.15	443.08	360.03	210.80
Increase/Decrease in Stocks	-50.57	-80.28	-147.36	64.28	30.42
Employees Cost	736.57	788.49	786.57	710.44	700.96
Depreciation	125.21	122.74	120.28	117.79	151.34
Other Expenses	869.66	914.60	975.24	835.45	862.13
Total Expenses	2820.39	2910.06	2952.16	2773.76	2709.95

P/L Before Other Inc. , Int., Excpt. Items & Tax	435.82	477.49	481.63	470.42	353.01
Other Income	11.69	31.13	39.42	31.49	773.17
P/L Before Interest, Excpt. Items & Tax	447.51	508.62	521.05	501.92	1126.17
Interest	66.71	52.29	48.48	39.58	148.56
P/L Before Exceptional Items & Tax	380.79	456.33	472.57	462.33	977.61
Exceptional Items	-372.82	0.00	0.00	0.00	-446.78
P/L Before Tax	7.97	456.33	472.57	462.33	530.83
Tax	3.59	108.30	118.09	122.10	1769.47
P/L After Tax from Ordinary Activities	4.38	348.03	354.49	340.24	-1238.65
Extra Ordinary Item	0.00	0.00	0.00	0.00	24.38
Net Profit/Loss For the Period	4.38	348.03	354.49	340.24	-1214.27
Minority Interest	0.27	-0.07	-0.27	0.03	-4.01
Net P/L After Minority Interest & Share Of Associates	4.65	347.96	354.21	340.27	-1218.28

Equity Share Capital	28.22	28.22	28.22	28.22	28.22
EPS Before Extra Ordinary *
Basic EPS (Rs.)	0.16	12.33	12.55	12.06	-43.18
Diluted EPS (Rs.)	0.16	12.33	12.55	12.06	-43.18
EPS After Extra Ordinary *
Basic EPS (Rs.)	0.16	12.33	12.55	12.06	-43.18
Diluted EPS (Rs.)	0.16	12.33	12.55	12.06	-43.18

PBITOE Margin (%)	13.38	14.09	14.02	14.50	11.52
PBTE Margin (%)	11.69	13.47	13.76	14.25	31.91
PBT Margin (%)	0.24	13.47	13.76	14.25	17.33
PAT Margin (%)	0.13	10.27	10.32	10.48	-39.64
PAT After MI And SOA Margin (%)	0.14	10.27	10.31	10.48	-39.77

Particulars	Mar 25
Net Sales/Income from operations	3220.13
Other Operating Income	36.07
Total Income From Operations	3256.21

EXPENDITURE
Consumption of Raw Materials	794.78
Purchase of Traded Goods	344.74
Increase/Decrease in Stocks	-50.57
Employees Cost	736.57
Depreciation	125.21
Other Expenses	869.66
Total Expenses	2820.39
P/L Before Other Inc. , Int., Excpt. Items & Tax	435.82
Other Income	11.69
P/L Before Interest, Excpt. Items & Tax	447.51
Interest	66.71
P/L Before Exceptional Items & Tax	380.79
Exceptional Items	-372.82
P/L Before Tax	7.97
Tax	3.59
P/L After Tax from Ordinary Activities	4.38
Extra Ordinary Item	0.00
Net Profit/Loss For the Period	4.38
Minority Interest	0.27
Net P/L After Minority Interest & Share Of Associates	4.65
Equity Share Capital	28.22
EPS Before Extra Ordinary *
Basic EPS (Rs.)	0.16
Diluted EPS (Rs.)	0.16
EPS After Extra Ordinary *
Basic EPS (Rs.)	0.16
Diluted EPS (Rs.)	0.16
PBITOE Margin (%)	13.38
PBTE Margin (%)	11.69
PBT Margin (%)	0.24
PAT Margin (%)	0.13
PAT After MI And SOA Margin (%)	0.14